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The UL33 protein is one of six genes (including UL6, UL15, UL17, UL28, and UL32) required for cleavage of viral concatemeric
DNA into unit-length genomes and packaging of the virus genomes into preformed capsids. The UL25 gene product is
dispensable for cleavage of viral DNA but essential for packaging of DNA into capsids. A polyclonal antiserum was produced
against an affinity-purified protein containing the full-length UL33 gene product of herpes simplex virus 1 fused to
glutathione-S-transferase. A protein of approximate Mr 19,000 that reacted with the antiserum was detected in immunoblots
of herpes simplex virus 1-infected cellular lysates. This protein was not detected in lysates of mock-infected cells or cells
infected with a mutant virus containing a stop codon in UL33, indicating that the 19,000 Mr protein is the product of the UL33
open reading frame. The UL33 gene product was not detected in purified virions or capsids. Accumulation of the UL33 protein
to detectable levels required viral DNA synthesis, indicating that the protein was regulated as a late gene. Indirect
immunofluorescence analysis demonstrated that UL33 protein accumulated predominantly within replication compartments
in the central domains of infected cell nuclei and within the cytoplasm. Localization of the UL33 gene product in replication
compartments was maintained in cells infected with a variety of cleavage/packaging mutants. © 2000 Academic Press
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tINTRODUCTION
During infection with herpes simplex virus 1 (HSV-1),
viral DNA is replicated in nuclei of infected cells and
accumulates as head-to-tail concatemers (Ben-Porat and
Tokazewski, 1977; Jacob and Roizman, 1979). Unit-length
genomes are cleaved from the concatemeric DNA and
inserted into preformed capsids (Deiss and Frenkel,
1986; Sears and Roizman, 1990). DNA-containing cap-
sids are then initially enveloped at the inner nuclear
membrane to become virions (Roizman and Furlong,
1974; Roizman and Sears, 1996).
Late in infection, concatemeric viral DNA accumulates
in replication compartments that are centrally located in
infected cell nuclei, in regions largely separated from
marginated cellular chromatin (de Bruyn Kops and Knipe,
1994). Replication compartments contain a variety of pro-
teins, including (1) enzymes and other proteins like ICP8,
the major single-stranded DNA binding protein, required
for viral DNA synthesis (Quinlan et al., 1984); (2) the
regulatory protein ICP4 (Knipe et al., 1987); and (3) UL15,
protein required for cleavage of concatemeric DNA and
nsertion of unit-length genomes into preformed capsids
Baines et al., 1994; Lamberti and Weller, 1998; Ward et
l., 1996). These data suggest that viral DNA replication,
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31nd at least some steps of viral DNA cleavage and
ncapsidation, occurs in viral replication compartments.
This study focuses on the UL33 gene product. Like
L6, UL15, UL17, UL28, and UL32 gene products, the UL33
gene product is required for the cleavage of concate-
meric viral DNA into unit-length molecules (al-Kobaisi et
al., 1991; Addison et al., 1984, 1990; Poon and Roizman,
1993; Salmon et al., 1998b; Sherman and Bachenheimer,
987, 1988). In the absence of these proteins, B capsids
acking DNA accumulate in infected cell nuclei, whereas
NA-containing C capsids are not detected. The nuclei
f cells infected with a UL25 mutant virus contain both A
and B capsids, yet no detectable C capsids (McNab, et
al., 1998). Small amounts of proteins encoded by UL6,
UL15, UL25, and UL28 can be detected in B capsids,
uggesting that these proteins mediate DNA packaging
y directly or indirectly linking incoming DNA with the
apsid (Patel and Maclean, 1995; McNab et al., 1998;
aus and Baines, 1998a; Yu and Weller, 1998; Salmon
nd Baines, 1998a). Conversely, UL17 is not stably asso-
ciated with intranuclear capsids but is required for
proper trafficking of capsid proteins and capsids into
replication compartments late in infection (Taus et al.,
1998b). UL17 is subsequently incorporated into virions by
n unknown mechanism (Salmon et al., 1998b).
Basic Local Alignment Search Tool (BLAST) analysis
f the predicted amino acid sequence of HSV-1 UL33
ndicates significant amino acid sequence homology in
he genomes of other members of Alphaherpesvirinae.
he protein encoded by HSV-1 UL33, or homologous
proteins in other herpesviruses, have yet to be identified.
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311UL33 GENE PRODUCT OF HSV 1The goal of this study was to characterize the UL33 gene
roduct of HSV-1 in infected cells.
RESULTS
dentification of UL33 protein
To characterize the UL33 gene product of HSV-1, a New
ealand White rabbit was immunized against an affinity-
urified fusion protein containing glutathione-S-trans-
erase fused to full-length UL33 protein as described in
aterials and Methods. To test the specificity of the
abbit antiserum, HEp-2 cells were mock infected or
ere infected with 5.0 PFU/cell wild-type virus [HSV-1(F)]
r a viral mutant containing a stop codon in UL33
[UL33(2)] virus (Cunningham and Davison, 1993). Eigh-
teen hours later, proteins in lysates of the infected cells
were electrophoretically separated on a denaturing poly-
acrylamide gel. Identical samples of lysates were elec-
trically transferred to two separate nitrocellulose mem-
branes. One sheet was probed with the novel rabbit
antiserum directed against UL33-GST protein, and one
as probed with a previously described antiserum di-
ected against the UL21-GST protein as described in
aterials and Methods (Baines and Roizman, 1994).
ound antibody was detected by reaction with alkaline
hosphatase-conjugated anti-rabbit antibody followed by
he addition of chromogenic substrate. The results are
hown in Fig. 1.
A protein of apparent Mr 19,000 was detected in lanes
ontaining lysates of cells infected with wild-type HSV-
(F) virus probed with the UL33 antiserum (Fig. 1, left
panel, lane WT). This protein was not detected in lanes
containing lysates of cells that were mock-infected (Fig.
1, left panel, lane M) or that were infected with the
UL33(2) mutant virus (Fig. 1, left panel, lane 332). Bands
FIG. 1. Digital scanned image of immunoblot probed with UL33-
pecific or UL21-specific antisera. HEp-2 cells were mock-infected
lane labeled M) or were infected with HSV-1(F) (labeled WT) or a virus
earing a stop codon in UL33 (labeled 332). Lysates were prepared
8 h p.i. Electrophoretically separated proteins were divided into two
qual aliquots and transferred to nitrocellulose. The membranes were
robed with antisera raised against a UL33-GST fusion protein or a
L21-GST fusion protein. Molecular weights are indicated in thousands
o the left of the figure.corresponding to high molecular weight proteins (Mr
.104,000) were detectable in lysates of both infected
p
icells and mock-infected cells, indicating these proteins
were not products of the UL33 gene. The position of
these proteins suggests that they were trapped at the
interface of the 5% stacking polyacrylamide and 15%
separating polyacrylamide gel. When the corresponding
nitrocellulose sheet was probed with UL21-specific anti-
erum, a band of approximate Mr 70,000 was detected in
anes containing lysates of cells infected with HSV-1(F)
nd UL33(2) mutant virus (Fig. 1, right panel, lanes WT
nd 332, respectively) but not in mock-infected cell ly-
ates (Fig 1, right panel, lane M). These findings are
onsistent with previous data indicating that the UL21
ene product migrates with apparent Mr 66,000 (Baines
and Roizman, 1994). The difference in apparent Mr likely
reflects the fact the gel system used in this experiment
was not optimal for separation of proteins above approx-
imately 45,000 Mr. Inasmuch as the UL21 protein was
eadily detected in lysates of UL33(2)-infected cells, the
absence of immunoreactivity of the 19,000 Mr protein
with the UL33-GST antiserum is not attributable to poor
infection with the mutant virus or inability to express viral
proteins. It is concluded that the 19,000 apparent Mr
protein is the product of the UL33 gene inasmuch as the
rotein was present in cells infected with wild-type virus
nd was absent from cells infected with the UL33(2)
virus.
UL33 protein is expressed as a late gene product
In the absence of viral DNA synthesis, late gene prod-
cts are either not produced (g2 genes) or are expressed
at significantly lower levels (g1 genes) (Conley et al.,
1981; Costa et al., 1981; Jones and Roizman, 1979; Silver
and Roizman, 1985; Wagner, 1984). UL21 is expressed as
g1 gene (Baines and Roizman, 1994). To classify the
temporal regulation of the UL33 gene, two sets of exper-
iments were performed.
In the first experiment, lysates of HEp-2 cells infected
with HSV-1(F) were prepared at time points 0, 2, 4, 6, 12,
and 18 h postinfection (p.i.) from 25-cm2 flasks of HEp-2
cells infected with 5.0 PFU/cell of HSV-1(F) virus. Lysates
were divided, and half of the protein isolated at each time
point was electrophoretically separated, transferred to
nitrocellulose, and probed with UL33-GST antiserum, as
described in Materials and Methods. The results are
shown in Fig. 2. UL33 protein was detectable as early as
4 h p.i. and remained detectable as late as 18 h p.i.
Surprisingly, levels of UL33 protein peaked at approxi-
ately 12 h after infection, and the amount of accumu-
ated UL33 protein-specific immunoreactivity was ap-
proximately twofold greater than at other time points
even though the total amount of protein loaded in each
lane was comparable.
Equal amounts of UL21 protein were detectable at 12 h
.i. compared with 18 h p.i. by immunoblot analysis of
dentical lysates probed for UL33 protein. The aforemen-
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312 REYNOLDS, FAN, AND BAINEStioned results were confirmed in three separate experi-
ments. These data suggest that significant amounts of
UL33 protein are degraded or lost between 12 and 18 h
after infection.
In the second experiment, HEp-2 cells were infected
with 5.0 PFU/cell HSV-1(F) in the presence or absence of
phosphonoacetic acid (PAA), a viral DNA synthesis in-
hibitor. Eighteen hours later, cells were harvested and
proteins were electrophoretically separated, transferred
to nitrocellulose, and probed with UL33-specific or UL21-
pecific antisera. The results are shown in Fig. 3.
The 19,000 apparent Mr protein recognized by the
UL33-specific antiserum was readily detected in lysates
harvested 18 h p.i. infected in the absence of PAA. In the
presence of PAA, however, amounts of this protein were
reduced to undetectable levels. As expected, the amount
of the approximately 70,000 Mr UL21 protein was reduced
in the presence of PAA but remained detectable. Studies
of cells infected with wild-type virus in the presence or
absence of PAA and subsequently harvested at 0, 6, 12,
and 18 h p.i. also indicated that no UL33 protein could be
etected in PAA-treated cells, whereas UL21 protein was
etectable in reduced amounts in PAA-treated cells at 6,
2, and 18 h p.i. (data not shown). These experiments
ndicate that accumulation of UL33 protein to detectable
evels requires viral DNA synthesis and suggest that the
L33 protein accumulates as a true late, or g2, gene
roduct.
he UL33 protein is localized in nuclear replication
ompartments late in infection
FIG. 2. Scanned digitized image of immunoblot of HSV-1(F)-infected
HEp-2 lysates probed with UL33-GST antiserum. Cells were harvested
t 0, 2, 4, 6, 12, and 18 h p.i. Associated proteins were electrophoreti-
ally separated on a denaturing acrylamide gel, transferred to a nitro-
ellulose membrane, and probed with the UL33-GST antiserum. Bound
immunoglobulin was visualized by reaction with alkaline phosphatase
conjugated goat anti-rabbit immunoglobulin followed by fixation of
colored substrate.To localize UL33 proteins in infected cells, HEp-2 cells
ere infected with wild-type HSV-1(F) virus and thenixed and permeabilized 18 h p.i. Cells were incubated
ith rabbit antiserum directed against UL33 protein and
mouse monoclonal antibodies directed against either
ICP8 or ICP4 as described in Materials and Methods.
ICP8 is a marker for centrally located intranuclear do-
mains termed “replication compartments” (Quinlan et al.,
1984), and ICP4 protein also localizes in replication com-
partments late in infection (Knipe et al., 1987). Bound
antibody was visualized by reaction with Texas Red-
conjugated donkey anti-rabbit antiserum and fluores-
cein-conjugated donkey anti-mouse immunoglobulin.
Cells were viewed and images recorded as described in
Materials and Methods.
As shown in Fig. 4, in cells infected with wild-type
HSV-1(F), UL33 protein-specific staining was located pre-
ominantly within globular central nuclear domains and,
o a lesser extent, in the cytoplasmic region adjacent to
he nuclear membrane. As expected, ICP4 specific stain-
ng (green in Fig. 4) was located entirely within a central
ortion of the nucleus (replication compartments). Merg-
ng of the images indicated that in HSV-1(F)-infected
ells, the UL33 protein-specific nuclear staining colocal-
zed with ICP4. Colocalization was visualized as a yellow
olor on merging of the separate images.
In control experiments, cells were either mock infected
r infected with UL33(2) virus and subsequently stained
with UL33 antiserum and ICP4 monoclonal antibody, fol-
FIG. 3. Scanned images of immunoblots of lysates of HEp-2 cells
probed with UL33-GST or UL21-GST antisera. Cells were mock infected
(lane designated M) or infected with HSV-1(F) (lanes designated WT) in
the presence or absence of 300 mg/mL viral DNA synthesis inhibitor
PAA. Lysates of cells were harvested 18 h p.i. and were divided into two
equal aliquots. Proteins were electrophoretically separated and elec-
trically transferred to nitrocellulose membranes. Membranes were
probed with either UL33-specific antiserum (left) or UL21-specific anti-
serum (right).
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313UL33 GENE PRODUCT OF HSV 1lowed by reaction with appropriate secondary antibod-
FIG. 4. Digital images of HEp-2 cells infected with wild-type and
mutant viruses costained with UL33-GST antiserum and markers for
NA replication compartments. Cells were infected with wild-type
SV-1(F) virus (designated WT), gE(2) virus (designated gE2), or the
ndicated mutant viruses. Infected cells were fixed and permeabilized
8 h p.i. in ice-cold methanol and then reacted with rabbit UL33-GST-
specific and mouse monoclonal antibodies against ICP4 or ICP8.
Bound primary antibodies were visualized by reaction with Texas Red-
conjugated donkey anti-rabbit antibody and FITC-conjugated donkey
anti-mouse antibody. The bound conjugated antibodies were visualized
by light microscopy using filters appropriate for excitation of the re-
spective fluorochromes. Images were recorded separately (left and
middle columns) and subsequently merged with Slidebook software
(right column).ies. A faint amount of cytoplasmic fluorescence was
visible on reaction with the UL33-specific antiserum in
p
wboth mock-infected and UL33(2)-infected cells. The ob-
servation that the level of staining in mock-infected cells
was comparable to that seen in UL33(2)-infected cells
suggests that the low level of background staining was
due to limited cross reaction with cellular proteins. The
intensity of this background fluorescence was signifi-
cantly lower than in cells infected with viruses express-
ing UL33 protein. There was no detectable immunofluo-
rescence in nuclei of mock-infected cells or in cells
infected with the UL33 mutant. These data indicate that
he UL33 protein localizes in the cytoplasm and within
replication compartments of infected cells.
It was surprising that the UL33 protein, known to be
nvolved in the intranuclear event of DNA cleavage/pack-
ging, should accumulate to such high levels in the
ytoplasm of infected cells. To investigate the possibility
hat the putative cytoplasmic UL33-specific staining was
an artifactual consequence of interaction of the HSV-
encoded Fc receptor (encoded by glycoproteins E and I)
with rabbit immunoglobulin despite the human serum
blocking procedure detailed in Materials and Methods,
cells were infected with R7202, a glycoprotein E (gE2)
virus derived from HSV-1(F) (Baines and Roizman, 1993).
Cells were permeabilized 18 h after infection and were
stained with the UL33 antiserum and a monoclonal anti-
body directed against ICP8, followed by reaction with
appropriate secondary antibodies conjugated to fluores-
cein (donkey anti-mouse) or Texas Red (donkey anti-
rabbit). As expected, ICP8-specific staining was local-
ized within the central intranuclear replication compart-
ment of nuclei of infected cells. The pattern of
intranuclear UL33 protein staining coincided with regions
containing ICP8. The pattern of cytoplasmic staining in
cells infected with the gE mutant was similar to that seen
in cells infected with viruses expressing glycoprotein E
[compare Fig. 4 panels designated gE(2) with panels
designated HSV-1(F) WT, UL172, UL182, UL322, and
L332]. From these data, we conclude the cytoplasmic
staining attributed to the UL33 protein reflected the pres-
ence of the UL33 protein in the infected cell cytoplasm
and was not a consequence of nonspecific virally en-
coded Fc receptor interaction with rabbit immunoglobu-
lin.
Expression of viral DNA cleavage/packaging gene
products is not necessary for nuclear
localization of UL33 protein
To test the possibilities that other gene products
known to be required for DNA cleavage/packaging me-
diated nuclear import or nuclear trafficking of UL33 pro-
ein, we took advantage of the availability of a wide
ariety of mutant viruses lacking individual genes re-
uired for DNA cleavage/packaging. The experimental
redictions were that (1) UL33 protein would remain
ithin the cytoplasm of cells infected with a virus lacking
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314 REYNOLDS, FAN, AND BAINESa gene necessary for nuclear import or (2) if a gene was
necessary for correct localization within intranuclear rep-
lication compartments, UL33 protein would not be pre-
dicted to colocalize with ICP4 in replication compart-
ments in cells infected with the corresponding viral mu-
tant.
To test these possibilities, HEp2 cells were infected
with individual viruses lacking functional UL6, UL15, UL17,
L18, UL28, or UL32 genes and were fixed and perme-
abilized 18 h after infection as described in Materials and
Methods. Cells were costained with the UL33-GST rabbit
antiserum and a monoclonal antibody directed against
ICP4. Bound immunoglobulin was visualized by reaction
with appropriate secondary antibody conjugates as de-
scribed above. As a representation of the data obtained,
images of cells infected with viruses lacking functional
UL17 and UL32 are shown in Fig. 4. Identical results were
obtained in similarly stained cells infected with viruses
lacking UL6, UL15, or UL28 (data not shown). The staining
patterns resembled those observed in cells infected with
wild-type HSV-1(F). Specifically, UL33 protein (stained
red) was detectable in intranuclear regions containing
ICP4 (stained green) as revealed by the production of a
yellow color on merging of images collected separately
in light filtered optimally for excitation of the respective
conjugates.
To test the possibility that proper localization of UL33
as dependent on capsid assembly, cells were infected
ith a virus (K23Z) lacking UL18, a triplex precursor
(Desai et al., 1993). The infected cells were fixed and
permeabilized 18 h after infection and reacted with the
UL33-GST antiserum and ICP4 monoclonal antibody as
indicated above. The data, an example of which is shown
in Fig. 4, indicated that UL33 protein colocalized with
ICP4 in replication compartments and within a perinu-
clear cytoplasmic region in cells infected with the UL18
eletion mutant.
Taken together, these data indicate that the UL33 pro-
ein can accumulate within replication compartments
ndependently of functional DNA cleavage/packaging
nd in the absence of capsid assembly. The data support
he conclusions that none of the known DNA cleavage/
ackaging gene products are individually required for
uclear localization of UL33 protein or intranuclear traf-
ficking of UL33 protein to sites within DNA replication
compartments.
UL33 protein is not present at detectable levels in
irions or capsids
Virions were purified from two 850-cm2 roller bottles of
Vero cells infected for 40 h with HSV-1(F) at 3.0 PFU/cell
and held at 34°C as described in Materials and Meth-
ods. Virion-associated proteins were electrophoretically
separated in denaturing 10% and 15% polyacrylamide
gels. Approximately half of the virion proteins in a given
s
ppreparation were transferred to nitrocellulose and
probed with the UL33-GST antiserum; the results are
shown in Fig. 5. No UL33-specific band was detectable in
immunoblots probed with the UL33-specific antiserum;
however, the possibility that UL33 protein accumulates
ithin virions at levels below those detectable by immu-
oblot analysis cannot be excluded. The presence of
urified virion proteins in the preparations was con-
irmed by two methods. In the first method, the immuno-
lot previously reacted with UL33-specific antiserum was
probed with antiserum directed against the UL21 protein.
s seen in Fig. 5A, a band specific for UL21 protein was
eadily detectable, indicating virion proteins were bound
o the nitrocellulose membrane. In the second method,
lectrophoretically resolved virion proteins constituting
5% of the same sample demonstrated in Fig. 5B were
FIG. 5. (A) Scanned image of immunoblot of lysates containing
purified virions probed with antisera directed against UL33- and UL21-
ncoded proteins. Approximately 50% of the total sample was electro-
horetically separated on a 15% polyacrylamide gel, transferred to
itrocellulose, probed with UL33 antiserum, and subsequently probed
ith UL21-specific antisera. The positions of relevant size markers are
hown and their Mr values are indicated in thousands. (B) Coomassie-
stained 10% polyacrylamide gel containing 25% of the identical purified
virion sample demonstrated in Fig. 5A. Virion proteins (labeled VP) are
indicated to the left according to published designations (Spear and
Roizman, 1972). To the right of the virion sample, the positions of size
standards are shown and corresponding Mr values are depicted in
housands.tained with Coomassie Brilliant Blue R 250. The protein
rofiles, shown in Fig. 5B, resembled previously de-
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315UL33 GENE PRODUCT OF HSV 1scribed characterizations of viral protein staining pat-
terns and demonstrated ample amounts of virion pro-
teins within the sample (Spear and Roizman, 1972).
To determine whether UL33 was associated with cap-
sids, B and C capsids were purified from HSV-1-infected
Vero cells at 18 h p.i. and analyzed by immunoblot assay
for the presence of UL33 protein (data not shown). No
protein was detected in either B or C capsids, but the
possibility could not be ruled out that UL33 protein ac-
umulated in capsids to levels below those detectable by
mmunoblot analysis.
DISCUSSION
The UL33 gene product of HSV-1 has been shown to
e required for DNA cleavage/packaging (al-Kobaisi et
l., 1991). As a step toward understanding the role of
L33 in this process, the UL33 protein was characterized.
he predicted size of the UL33 protein is approximately
4,400 Da (McGeoch et al., 1988). In the studies reported
herein, the UL33 protein migrated with apparent Mr
19,000. The discrepancy between the predicted and ac-
tual Mr values may be due to proline-rich regions en-
coded within the UL33 open reading frame that can
cause aberrant migration of proteins in SDS–polyacryl-
amide gels.
The data in this report indicate that UL33 protein lo-
calizes within nuclear replication compartments, provid-
ing further support to the hypothesis that at least some
steps of DNA cleavage/packaging occur within these
sites (Lamberti and Weller, 1998; Taus et al., 1998b; Ward
et al., 1996). Nuclear localization of UL33 protein occurs
in cells infected with viral mutants defective in cleavage/
packaging and capsid assembly. Parenthetically, we de-
tected some UL33 protein-specific staining in the repli-
ation compartments as early as 4 h p.i., with minimal
lteration in distribution of the protein between 4 and
0 h p.i. (data not shown).
Data presented herein also indicate that the UL33
protein localizes within the cytoplasm of infected cells.
Although on initial examination this localization pattern
appears inconsistent with a role in DNA cleavage and
packaging, it is not unprecedented. The UL32 protein is
lso required for DNA cleavage/packaging and localizes
argely within the cytoplasm of infected cells and, to a
esser extent, in the nuclei of infected cells (Lamberti and
eller, 1998; Chang et al., 1996) One possibility is that
ytoplasmic localization reflects a preliminary step in
hich protein complexes containing UL33 and UL32 as-
emble before their import into the nucleus. Alternatively,
he UL33 and UL32 proteins may perform functions in
ddition to their roles in DNA cleavage and packaging.
We noted that transiently overexpressed UL33 protein
localizes exclusively in the cytoplasm of uninfected cells
and remains largely refractory to nuclear import when
these cells are subsequently infected with a variety of
d
(wild-type and mutant viruses (data not shown). The ob-
servation that overexpressed UL33 protein localized ex-
lusively in the cytoplasm was surprising inasmuch as
he size of UL33 protein is not expected to exceed the
exclusion limit of the nuclear pore (Pante and Aebi, 1995;
Davis, 1995); thus some diffusion into the nucleus was
expected. This observation suggests either that UL33
protein requires coexpression of viral proteins for correct
partnering or folding that lead to nuclear localization or
that when overexpressed, UL33 protein aggregates into
omplexes that exceed the size of the nuclear pore and
ack accessible nuclear import signals.
The UL6, UL15, UL25, and UL28 proteins have been
shown in previous reports to associate with B capsids,
suggesting that these proteins are directly involved in
linking DNA to the capsid, packaging the DNA, or retain-
ing the DNA within the capsid (Patel and Maclean, 1995;
McNab et al., 1998; Taus and Baines, 1998a; Yu and
Weller, 1998; Salmon and Baines, 1998a). In contrast, the
UL32 and UL33 proteins have been shown to be absent
rom capsids and purified virions. The absence of UL32
and UL33 proteins from capsids suggests they play very
ifferent roles from those of the minor capsid associated
roteins required for DNA cleavage/packaging. Possible
oles include (1) steps in DNA processing requiring only
transient association with DNA or capsids, (2) chaper-
ne-like functions to ensure correct folding and assem-
ly of other proteins into complexes pertinent to DNA
leavage/packaging, or (3) transport of other proteins or
rotein complexes. Notwithstanding these possibilities,
he roles of these proteins in the DNA cleavage/packag-
ng reaction remain to be elucidated.
MATERIALS AND METHODS
ells and viruses
All cell lines were maintained in 10% (v/v) newborn calf
erum supplemented with penicillin and streptomycin as
reviously described (Taus et al., 1998b). HEp-2 cells
ere obtained from American Type Culture Collection
ATCC) Certified Cell Line (CCL no. 23). The HEp-2 cell
ine was derived from human laryngeal epidermoid car-
inoma tissue. The Vero cell line was initiated from
idney tissue harvested from a normal adult African
reen monkey and also was obtained from ATCC (CCL
o. 81).
The following viruses were used in this study: HSV-
(F) (strain of wild-type virus) (Ejercito et al., 1968), UL62
UL6 mutant virus derived from strain 17) (Patel et al.,
1996), HSV-1 (DUL15ExII) [UL15 mutant virus derived from
HSV-1(F)] (Baines et al., 1994), HSV-1 (DUL17) [UL17 mu-
tant virus derived from HSV-1(F) strain] (Salmon et al.,
1998b), UL182 (UL18 mutant virus derived from KOS
train) (Desai et al., 1993), KUL25NS (UL25 mutant virus
erived from HSV-1 KOS strain) (McNab et al., 1998), gCB
UL28 mutant virus derived from HSV-1 KOS strain) (Ten-
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316 REYNOLDS, FAN, AND BAINESgelsen et al., 1993), hr64 (UL32 mutant virus derived from
OS strain) (Lamberti and Weller, 1998), UL332 (UL33
utant virus derived from HSV-1 strain 17) (Cunningham
nd Davison, 1993), and R7202 (glycoprotein E mutant
irus derived from HSV-1(F) strain) (Baines and Roizman,
993). Viruses lacking genes required for production of
nfectious progeny were propagated on previously de-
cribed transformed cell lines as follows: G33, UL6 mu-
ant virus complementary cell line (Patel et al., 1996),
lone 17, UL15 mutant virus complementary cell line
(Baines et al., 1997), G5, UL17 and UL18 mutant viruses
complementary cell line (Desai et al., 1993), 8-1, UL25
utant virus complementary cell line (McNab et al.,
998), C1, UL28 complementary cell line, 158, UL32 mu-
ant virus complementary cell line (Lamberti and Weller,
998), and D4, UL33 mutant virus complementary cell line
(Salmon et al., 1999). To test for the presence of revertant
viruses, viral stocks were titered on wild-type Vero cells
and the appropriate complementary cell lines. Stocks
that produced titers at least 10,000-fold higher on com-
plementary cells than on Vero cells were used for further
studies.
The plasmid pRB4735 contained a 1.35-kbp EcoRI “O”
fragment of the HSV-1 genome cloned into pGEM-3Z
(Promega, Madison, WI). The full-length UL33 gene was
cloned from pRB4735 into the SmaI–EcoRI sites of the
pGEX-2T fusion vector (Amersham Pharmacia Biotech)
in-frame with the gene encoding GST. The junction of the
two genes was sequenced to ensure that the respective
open reading frames were maintained (not shown); the
plasmid was designated pJB93. Full-length UL33 was
also cloned into the EcoRI–HindIII site of pcDNA3 (In-
Vitrogen) such that expression was under the control of
the human cytomegalovirus (CMV) immediate-early gene
promoter. This plasmid was designated pJB100.
Antibodies and immunoblotting
To produce an antiserum directed against UL33-en-
oded protein, the BL21 strain of Escherichia coli was
ransformed with pJB93. Expression of a soluble fusion
rotein of approximate Mr 45,000 was induced at 30°C
with 0.1 mM isopropyl b-D-thiogalactoside. The UL33-GST
usion protein was purified by affinity chromatography on
lutathione-conjugated Sepharose 4B beads (Amersham
harmacia Biotech). New Zealand White rabbits were
mmunized with the purified protein as described (Baines
nd Roizman, 1993).
Mock-, HSV-1(F)-, and UL33(2)-infected HEp-2 cellular
ysates from 25-cm2 flasks infected with 5 PFU/cell were
repared 18 h p.i. in PBSA* [PBS, pH 7.4, supplemented
ith 1.0% Triton X-100, 1.0% sodium deoxycholate, 10 mM
TLCK (a-tosyl-L-lysine chloromethyl ketone), and 10 mM
TPCK (tolylsulfonyl phenyalanyl chloromethyl ketone)].
The samples were divided into two equal aliquots and
were electrophoretically separated on a denaturing 15%
i
aSDS–polyacrylamide gel. The proteins were electrically
transferred to two separate nitrocellulose membranes
and were probed with either (1) the UL33 antiserum
iluted 1:200 in PBS containing 1% (w/v) BSA and 1% (v/v)
ween 20 detergent or (2) a UL21-specific antiserum
prepared and diluted 1:1000 as described (Baines and
Roizman, 1994). In some cases, lysates for immunoblot-
ting were prepared from cells infected or mock infected
in the presence of 300 mg/mL PAA. The amount of total
rotein loaded in lanes labeled 4, 6, 12, and 18 h p.i.
uring the time course experiment (shown in Fig. 2) was
etermined with a modified Bradford assay standardized
gainst BSA according to the manufacturer’s protocol
Bio-Rad, Hercules, CA).
ndirect immunofluorescence assay
To preadsorb the UL33-specific antisera against pro-
eins other than UL33, HEp-2 cells from four 850-cm
2
roller bottles (approximately 5 3 108 cells) were infected
ith UL33(2) virus at 5.0 PFU/cell. At 18 h p.i., cells were
harvested and washed extensively with PBS, and pro-
teins were precipitated in 10 volumes of ice-cold ace-
tone. The UL33 polyclonal serum (1.2 ml diluted 1:60 in
old 1% BSA/PBS) was added to the precipitated pro-
eins, and the mixture was agitated for 12 h at 4°C. An
qual volume of cold 1% BSA/PBS was added after ab-
orption of the polyclonal antiserum to bring the final
ilution of the UL33 polyclonal serum to 1:120 for use in
indirect immunofluorescence assays.
Indirect immunofluorescence to localize UL33 protein
n infected cells was performed as follows. Sterilized
lass cover slips were placed in 10-cm2 wells of a 6-well
dish, and approximately 50,000 cells were added to each
well. The cells were incubated in growth medium for
10–16 h and subsequently infected with wild-type HSV-1
virus or mutant viruses (1.0 PFU/cell). At 18 h p.i., cells
were fixed and permeabilized for 20 min in ice-cold
methanol and then rinsed extensively with PBS. Perme-
abilized infected cells were incubated with 10% filtered
(0.20-mm syringe top filter) human serum (Sigma
2145)/1% BSA in sterile PBS for 1 h at room temperature
o block nonspecific binding of rabbit immunoglobulin by
he HSV-encoded Fc receptor containing glycoprotein E
nd glycoprotein I (Johnson et al., 1988). Cells were
costained with preadsorbed UL33 polyclonal antiserum
iluted 1:120 in 1% (w/v) BSA in PBS and either 1:1000
CP8 or 1:1000 ICP4 mouse monoclonal antibody (Good-
in Institute for Cancer Research, monoclonal antibod-
es 1115 or 1114, respectively). After a 45-min incubation
eriod at 37°C in a humidified chamber, cells were
insed extensively with PBS and incubated with the ap-
ropriate fluorochrome-conjugated antibody diluted in
BS supplemented with 1% BSA. Bound primary antibod-es were visualized with Texas Red-conjugated donkey
nti-rabbit immunoglobulin or fluorescein isothiocya-
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317UL33 GENE PRODUCT OF HSV 1nate-conjugated donkey anti-mouse immunoglobulin
(Jackson ImmunoResearch Laboratories, Inc.) diluted
1:100 in 1.0% BSA-supplemented PBS. Cells were then
washed extensively in PBS and rinsed briefly in distilled
water.
Excess liquid was removed by blotting with bibulous
paper, and the moist cover-slips were mounted on glass
slides with Mowiol mounting media containing 1,4-di-
azobibyclo[2,2,2]-octane (DABCO) reagent (Calbiochem).
Slides were viewed in a Zeiss Axioplan fluorescence
microscope using a 340 air objective and 310 ocular
objective in light filtered to excitatory wavelengths. Dig-
ital images were recorded with a CCD camera and Slide-
book software version 2.5.1 (Intelligent Imaging Innova-
tions, Inc.) and printed with a Codonics NP 1600 dye
sublimation printer.
Virion purification and analysis
Virions were purified on dextran gradients from two
850-cm2 roller bottles of Vero cell monolayers as de-
scribed previously (Spear and Roizman, 1972; Salmon
and Baines, 1998a). Electrophoretically separated virion
proteins were electrically transferred to a nitrocellulose
membrane and probed with preadsorbed UL33 anti-
erum diluted 1:200 in PBS prepared as previously de-
cribed under Materials and Methods. The membrane
as then incubated overnight in an excess volume of a
% milk (w/v)/1% Tween 20 (v/v)/1% (w/v)BSA solution
nd subsequently probed with UL21-specific antiserum
Baines and Roizman, 1994).
An aliquot consisting of 25% of the purified viral sam-
le was separated on a denaturing 10% SDS–polyacryl-
mide gel and then stained with Coomassie Brilliant Blue
250 (Sigma B0149). The apparent Mr values of virion-
ssociated proteins were calculated based on migration
f protein standards (Bio-Rad), and proteins were desig-
ated as described previously (Spear and Roizman,
972).
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Note added in proof. Roller et al., (2000) have noted that UL33 mRNA
is detectable at 8 h postinfection in the presence of PAA but is reduced
to nondetectable levels at 12 and 18 h postinfection. Taken with our
observations that UL33 protein is not detectable at any time point in the
resence of PAA, this suggests that DNA synthesis is necessary for
ormal transcription and translation of UL33 mRNA.
REFERENCESAddison, C., Rixon, F. J., Palfreyman, J. W., O’Hara, M., and Preston, V.
G.(1984). Characterisation of a herpes simplex virus type 1 mutantwhich has a temperature-sensitive defect in penetration of cells and
assembly of capsids. Virology 138, 246–259.
Addison, C., Rixon, F. J., and Preston, V. G. (1990). Herpes simplex virus
type 1 UL28 gene product is important for the formation of mature
capsids. J. Gen. Virol. 71, 2377–2384.
al-Kobaisi, M. F., Rixon, F. J., McDougall, I., and Preston, V. G. (1991). The
herpes simplex virus UL33 gene product is required for the assembly
of full capsids. Virology 180, 380–388.
Baines, J. D., Cunningham, C., Nalwanga, D., and Davison, A. J. (1997).
The UL15 gene of herpes simplex virus type 1 contains within its
second exon a novel open reading frame that is translated in frame
with the UL15 gene product. J. Virol. 71, 2666–2673.
aines, J. D., Poon, A. P. W., Rovnak, J., and Roizman, B. (1994). The UL15
gene of herpes simplex virus encodes two proteins and is required
for cleavage of viral DNA. J. Virol. 68, 8118–8124.
Baines, J. D., and Roizman, B. (1993). The UL10 gene of herpes simplex
virus 1 encodes a novel glycoprotein, gM, which is present in the
virion and in the plasma membrane of infected cells. J. Virol. 67,
1441–1452.
aines, J. D., and Roizman, B. (1994). The UL21 gene of herpes simplex
virus 1 is dispensable for replication in cell culture. J. Virol. 68,
2929–2936.
en-Porat, T., and Tokazewski, S. (1977). Replication of herpes virus
DNA. II. Sedimentation characteristics of newly synthesized DNA.
Virology 79, 292–301.
Chang, Y. E., Poon, A. P., and Roizman, B. (1996). Properties of the
protein encoded by the UL32 open reading frame of herpes simplex
virus 1. J. Virol. 70, 3938–3946.
Conley, A. J., Knipe, D. M., Jones, P., and Roizman, B. (1981). Molecular
genetics of herpes simplex virus. VII. Characterization of a temper-
ature sensitive mutant produced by in vitro mutagenesis and defec-
tive in DNA synthesis and accumulation of gamma polypeptides.
J. Virol. 37, 191–206.
Costa, R. H., Devi, B. G., Anderson, K. P., Gaylord, B. H., and Wagner,
E. K. (1981). Characterization of a major late herpes simplex virus
type 1 mRNA. J. Virol. 38, 483–496.
Cunningham, C., and Davison, A. J. (1993). A cosmid-based system for
constructing mutants of herpes simplex virus type 1. Virology 197,
116–124.
Davis, L. L. (1995). The nuclear pore complex. Annu. Rev. Biochem. 64,
865–896.
de Bruyn Kops, A., and Knipe, D. M. (1994). Preexisting nuclear archi-
tecture defines the intranuclear location of herpesvirus DNA repli-
cation structures. J. Virol. 68, 3512–3526.
Deiss, L. P., and Frenkel, N. (1986). Herpes simplex virus amplicon:
cleavage of concatemeric DNA is linked to packaging and involves
amplification of the terminally reiterated a sequence. J. Virol. 57,
933–941.
Desai, P., DeLuca, N. A., Glorioso, J. C., and Person, S. (1993). Mutations
in herpes simplex virus type 1 genes encoding VP5 and VP23
abrogate capsid formation and cleavage of replicated DNA. J. Virol.
67, 1357–1364.
Ejercito, P. M., Kieff, E. D., and Roizman, B. (1968). Characterization of
herpes simplex virus strains differing in their effects on social be-
havior of infected cells. J. Gen. Virol. 2, 357–364.
Jacob, R. J., and Roizman, B. (1979). Anatomy of herpes simplex virus
DNA. XII. Accumulation of head to tail concatemers in nuclei of
infected cells and their role in the generation of four isomeric ar-
rangements of viral DNA. J. Virol. 29, 448–457.
Johnson, D. C., Frame, M. C., Ligas, M. W., Cross, A. M., and Stow, N. D.
(1988). Herpes simplex virus immunoglobulin G Fc receptor activity
depends on a complex of two viral glycoproteins, gE and gI. J. Virol.
62, 1347–1354.
Jones, P. C., and Roizman, B. (1979). Regulation of herpesvirus macro-
molecular synthesis. VIII. The transcription of three phases during
which both extent of transcription and accumulation of RNA in the
cytoplasm are regulated. J. Virol. 31, 299–314.
LL
M
M
P
P
P
P
Q
R
R
R
S
S
S
S
318 REYNOLDS, FAN, AND BAINESKnipe, D. M., Senechek, D., Rice, S. A., and Smith, J. L. (1987). Stages in
the nuclear association of the herpes simplex virus transcriptional
activator protein ICP4. J. Virol. 61, 276–284.
amberti, C., and Weller, S. K. (1998). The herpes simplex virus type 1
cleavage/packaging protein, UL32, is involved in efficient localization
of capsids to replication compartments. J. Virol. 72, 2463–2473.
ehman, I. R., and Boehmer, P. E. (1999). Replication of herpes simplex
virus DNA. J. Biol. Chem. 274, 28059–28062.
cGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C.,
McNab, D., Perry, L. J., Scott, J. E., and Taylor, P. (1988). The complete
DNA sequence of the long unique region in the genome of herpes
simplex virus type 1. J. Gen. Virol. 69, 1531–1574.
cNab, A. R., Desai, P., Person, S., Roof, L. L., Thomsen, D. R., New-
comb, W. W., Brown, J. C., and Homa, F. L. (1998). The product of the
herpes simplex virus type 1 UL25 gene is required for encapsidation
but not for cleavage of replicated DNA. J. Virol. 72, 1060–1070.
ante, N, and Aebi, U. (1995). Exploring nuclear pore complex structure.
J. Cell Sci. 19, 1–11.
atel, A. H., and Maclean, J. B. (1995). The product of the UL6 gene of
herpes simplex virus type 1 is associated with virus capsids. Virology
206, 465–478.
atel, A. H., Rixon, F. J., Cunningham, C., and Davison, A. J. (1996).
Isolation and characterization of herpes simplex virus type 1 mutants
defective in the UL6 gene. Virology 217, 111–123.
oon, A. P. W., and Roizman, B. (1993). Characterization of a tempera-
ture-sensitive mutant of the UL15 open reading frame of herpes
simplex virus 1. J. Virol. 67, 4497–4503.
uinlan, M. P., Chen, L. B., and Knipe, D. M. (1984). The intranuclear
location of a herpes simplex virus DNA-binding protein is determined
by the status of viral DNA replication. Cell 36, 857–868.
oizman, B., and Furlong, D. (1974). “Comprehensive Virology,” 3rd Ed.
(Fraenkel-Conrat, H. and Wagner, R. R., Eds.), pp. 229–403. Plenum
Press, New York.
oizman, B., and Sears, A. (1996). “Fields’ Virology,” 3rd Ed. (Fields,
B. N., Knipe, D. M., and Howley, P. M., Eds.) pp. 2231–2295. Lippin-
cott-Raven, Philadelphia.
oller, R. J., Zhou, Y., Schnetzer, R., Ferguson, J., and DeSalvo, D. (2000).
Herpes simples virus type 1 UL34 gene product is required for viral
envelopment. J. Virol. 74, 117–129.
almon, B., and Baines, J. D. (1998a). Herpes simplex virus DNA
cleavage and packaging: Association of multiple forms of UL15-
encoded proteins with B capsids requires at least the UL6, UL17 and
UL28 genes. J. Virol. 72, 3045–3050.
almon, B., Cunningham, C., Davison, A. J., Harris, W. J., and Baines,J. D. (1998b). The herpes simplex virus 1 UL17 gene encodes virion
tegument proteins that are required for cleavage and packaging of
viral DNA. J. Virol. 72, 3779–3788.
almon, B., Nalwanga, D., Fan, Y., and Baines, J. D. (1999). Proteolytic
cleavage near the N-terminus of capsid associated herpes simplex
virus 1 UL15 protein is linked to cleavage of genomic viral DNA.
J. Virol. 73, 8338–8348.
ears, A. E., and Roizman, B. (1990). Amplification by host cell factors
of a sequence contained within the herpes simplex virus genome.
Proc. Natl. Acad. Sci. USA 87, 9441–9444.
Sherman, G., and Bachenheimer, S. L. (1987). DNA processing in
temperature-sensitive morphogenetic mutants of HSV-1. Virology
158, 427–430.
Sherman, G., and Bachenheimer, S. L. (1988). Characterization of in-
tranuclear capsids made by ts morphogenetic mutants of HSV-1.
Virology 163, 471–480.
Silver, S., and Roizman, B. (1985). g2-Thymidine kinase chimeras are
identically transcribed but regulated as g2 genes in herpes simplex
virus genomes and as b genes in cell genomes. Mol. Cell. Biol. 5,
518–528.
Spear, P. G., and Roizman, B. (1972). Proteins specified by herpes
simplex virus V. Purification and structural proteins of the herpes
virion. J. Virol. 9, 143–159.
Taus, N. S., and Baines, J. D. (1998a). Herpes simplex virus DNA
cleavage and packaging: The UL28 gene product is a minor compo-
nent of B capsids. Virology 252, 443–449.
Taus, N. S., Salmon, B., and Baines, J. D. (1998b). The herpes simplex
virus 1 UL17 gene is required for localization of capsids and major
and minor capsid proteins to intranuclear sites where viral DNA is
cleaved and packaged. Virology 252, 115–125.
Tengelsen, L. A., Pedersen, N. E., Shaver, P. R., Wathen, M. W., and
Homa, F. L. (1993). Herpes simplex virus type 1 DNA cleavage and
encapsidation require the product of the UL28 gene: Isolation and
characterization of two UL28 deletion mutants. J. Virol. 67, 3470–
3480.
Wagner, E. K. (1984). “The Herpesviruses,” Vol. 3 (Roizman, B., Ed.), pp.
45–104. Plenum Press, New York/London..
Ward, P. L., Ogle, W. O., and Roizman, B. (1996). Assemblons: nuclear
structures defined by aggregation of immature capsids and some
tegument proteins of herpes simplex virus 1. J. Virol. 70, 4623–4631.
Yu, D., and Weller, S. K. (1998). Herpes simplex virus type 1 cleavage
and packaging proteins UL15 and UL28 are associated with B but not
C capsids during packaging. J. Virol. 72, 7428–7439.
